Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Talking it out: motivational interviews boost confidence in gestational diabetes management

NCT ID NCT06243939

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether motivational interviewing, a counseling approach, could help pregnant women with gestational diabetes feel more confident managing their health and improve their quality of life. 72 first-time pregnant women participated. The results may show if this simple conversation-based method can ease the burden of managing diabetes during pregnancy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

72 people

The number who actually took part.

Started

Jun 2023

Finished

Sep 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Being pregnant for the first time * Being diagnosed with gestational diabetes mellitus * 24-28. Being in the pregnancy week * Being able to speak and understand Turkish * Being 18 years or older * Having a single and viable fetus * Volunteering to participate in research * Having and being able to use a mobile phone * Having all check-ups at the same hospital and regularly throughout pregnancy, Exclusion Criteria: * Being diagnosed with diabetes mellitus (type 1, type 2 diabetes) before pregnancy * Having a psychiatric diagnosis, * Having a chronic disease * Having risk factors such as threat of premature birth, placenta previa, premature rupture of membranes * Having any disability that would prevent communication (deafness, hearing impairment, etc., use of languages other than Turkish), * Pregnant women who do not want to continue the study and give birth before the 37th week of pregnancy will be excluded from the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Gestational diabetes mellitus are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Meltem Akbaş

    Adana, Sarıçam, 01330, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.